Comment on

• Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.

  Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L. Gaspoz JM, et al. N Engl J Med. 2002 Jun 6;346(23):1800-6. doi: 10.1056/NEJM200206063462309. N Engl J Med. 2002. PMID: 12050341
• When increased therapeutic benefit comes at increased cost.

  Wood AJ. Wood AJ. N Engl J Med. 2002 Jun 6;346(23):1819-21. doi: 10.1056/NEJM200206063462313. N Engl J Med. 2002. PMID: 12050345 No abstract available.